Product category:
Microbiology
News Release from: Oxoid | Subject: Oxoid chromogenic candida agar
Edited by the Laboratorytalk Editorial
Team on 30 April 2004
Improved identification of candida
infections
Selective differential medium uses two chromogens to differentiate C albicans colonies from colonies of C tropicalis, C krusei, and other important candida species in a single incubation
Oxoid has launched a new chromogenic medium for the rapid identification of clinically important candida species Oxoid chromogenic candida agar (OCCA) is a selective differential medium that utilises two chromogens to differentiate C albicans colonies (green) from colonies of C tropicalis (dark blue), C krusei (pink brown) and other important candida species (beige, yellow and brown) in a single incubation
This article was originally published on Laboratorytalk on 18 Jan 2002 at 8.00am (UK)
Related stories
Test to detect C difficile toxin A
Clostridium difficile is thought to be present in up to a fifth of hospital patients, and can cause the life-threatening condition PMC. Oxoid reports continuing sales growth for its diagnostic test
Culture medium for water quality monitoring
Oxoid has launched its water plate count agar, a medium to permit the enumeration of culturable micro-organisms from water using a colony count technique
Candida species are responsible for the most frequently encountered opportunistic fungal infections and are increasingly responsible for hospital acquired infections.
Patients with impaired immune systems (such as transplant, cancer and Aids patients) and critically ill patients (such as those on ICU and those receiving broad-spectrum antibiotics) are most at risk from infection.
Studies have shown that, if an antifungal agent is not included in the initial therapy, a mortality rate of around 60% can be observed.
The incidence of serious candida infections has increased since the late 1980s, coinciding with the increase in immunocompromised and seriously ill patients.
Azoles are currently the most widely used of all antifungal agents.
C albicans, which is sensitive to azoles, is the most commonly encountered of the candida species in clinical practice.
However, other candida species are becoming increasingly prevalent and are problematic due to the emergence of strains that are resistant to amphotericin B and newer azoles.
By allowing good and rapid differentiation of C albicans from other candida species (including those that are resistant to azoles), OCCA helps to improve the initial therapy choice.
This should have a major impact on morbidity and mortality rates, and on the duration of hospitalisation associated with candida infections.
In a comparative evaluation, OCCA was shown to promote good growth of candida species and allowed detection of more C albicans strains at 24 hours than an alternative chromogenic medium.
OCCA also provided superior detection rates of mixed yeast cultures over traditional media, allowing both major and minor populations to be identified. Request a free brochure from Oxoid ...
• Oxoid: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
